In the press

Matthew Read comments on JUSC/BASC merger in Investment Week

Biotech trusts top performance charts in February

Matthew Read comments on the US smallers funds merger in Michael Nelson’s article:

“This may not be the outcome BASC’s board envisaged when the review began, but it looks like a pragmatic solution that gives shareholders a genuine choice while avoiding the risk of leaving behind a subscale trust.”

Read the article here